88981754 - SYNGENE

Information

• Trademark
• 88981754

• Source

• Serial Number

  88981754

• Registration Number

  6405032

• International Classifications

  • 35 - Advertising
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  August 16, 2018
  6 years ago

• Registration Date

  June 29, 2021
  3 years ago

• Transaction Date

  June 02, 2023
  a year ago

• Status Date

  June 29, 2021
  3 years ago

• Published for Opposition Date

  January 14, 2020
  5 years ago

• Location Date

  May 27, 2021
  3 years ago

• First Use Anywhere Date

  August 31, 2004
  20 years ago

• First Use In Commerce Date

  August 31, 2004
  20 years ago

• Status Code

  700

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  BRACEY, KAREN E

• Attorney Docket Number

  879374

  Attorney Name

  Julianne Abelman

  Law Office Assigned Location Code

  M70

• Owners

  • SYNGENE INTERNATIONAL LTD

Case File Statements

• DM0000: The mark consists of the word "Syngene" in stylized font.
• CC0000: Color is not claimed as a feature of the mark.
• GS0351: Business services, namely, formulation of best practices for drug discovery, formulation development, clinical supplies, large molecule development, antibody drug conjugates and clinical development services; consulting services in the field of medical practice management for others; business consulting and management in the field of clinical trials, namely, providing information management services; business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; regulatory submission management, namely, assisting others in preparing and filing applications for new drugs with governmental regulatory bodies; business management consulting services in the field of pharmaceuticals drug development; none of the aforesaid services relating to gel imaging and gel analysis applications
• GS0421: Scientific research and custom synthesis; scientific and clinical research in the field of medicine, pharmaceutical, nutraceuticals; scientific research and development; custom design and development of chemical reagents and biochemical assays; laboratory testing; laboratory testing services for research and development purposes; testing of pharmaceuticals; chemical engineering; drug discovery services; pharmaceutical drug development services; pharmaceutical products development; development of pharmaceutical preparations and medicines; scientific study and research in the field of reproduction, husbandry, and general health of animal; biotechnology research for determining the neuronal survival of molecules in animal models; research and development services in the field of antibodies, antibody technology; custom design and development of chemical reagents and biochemical assays; design, engineering, research, development and testing services in the field of polymeric materials, polymer synthesis, and materials customization for medical, scientific, and technological applications; toxicology services; toxicity analysis; toxicity testing for research purposes; conducting clinical trials; conducting clinical trials for scientific research for others; conducting clinical trials for pharmaceutical products; providing medical and scientific research information in the field of clinical trials; conducting early evaluations in the field of new pharmaceuticals; DNA analysis services for scientific research purposes; laboratory research in the field of gene expression; blood analysis services for scientific research purposes; analysis of human tissues for medical research; scientific services relating to the isolation and cultivation of human tissues and cells for research purposes; preparation of reports relating to scientific and technical research; analysis in the field of molecular biology; contract research services relating to molecular sciences; biological cloning services; structural and functional analysis of genomes; scientific and medical laboratory services; services of a chemical and/or biological laboratory; laboratory research services relating to pharmaceuticals; research and development and consultation related thereto in the field of antibodies, antibody technology, chemistry, bioinformatics, biomedical devices, biologics, biotechnology, biotherapeutics, biology, biochemical preparations, cell lines, cheminformatics, genetics and genetic engineering, gene expression systems, in vitro research, inhalation pharmaceuticals, molecular sciences, micro-organisms, nutrition, ophthalmic preparations, pharmacogenetics, pharmacokinetics, pharmacology, pharmaceuticals, polymers, peptide synthesis, protein, and solid state characterization; toxicokinetic analysis and toxicology services; scientific and technological services, namely, scientific research, development, analysis, testing, engineering, extraction, synthesis, purification and production in the field of antibodies, active pharmaceutical ingredients (API), biomolecules, cell bank characterization, chirality, chromosome aberration, clinical chemistry, cloning vector, cyclotides, DNA, flow cytometry, gas chromatography mass spectrometry, genes, immuno-pharmaceuticals, in vitro irritation, large molecule, liquid chromatography mass spectrometry, microbials, monomers, nanoparticles, natural products, peptides, proteins, RNA, supercritical fluid chromatography, small molecules and vaccines; none of the aforesaid services relating to gel imaging and gel analysis applications, and none of the aforesaid services in the field of agriculture, horticulture and forestry

Case File Event Statements

• 6/2/2023 - a year ago

  47 - TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Type: EWAF

• 6/2/2023 - a year ago

  46 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 6/2/2023 - a year ago

  45 - TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Type: ECDR

• 6/2/2023 - a year ago

  44 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 6/2/2023 - a year ago

  43 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 6/2/2023 - a year ago

  42 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN

• 6/2/2023 - a year ago

  41 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR

• 6/29/2021 - 3 years ago

  40 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 5/28/2021 - 3 years ago

  39 - NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Type: SUNA

• 5/27/2021 - 3 years ago

  38 - ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Type: CNPR

• 5/26/2021 - 3 years ago

  37 - STATEMENT OF USE PROCESSING COMPLETE Type: SUPC

• 5/6/2021 - 3 years ago

  36 - USE AMENDMENT FILED Type: IUAF

• 5/26/2021 - 3 years ago

  35 - DIVISIONAL PROCESSING COMPLETE Type: DPCC

• 5/6/2021 - 3 years ago

  34 - DIVISIONAL REQUEST RECEIVED Type: DRRR

• 5/26/2021 - 3 years ago

  33 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU

• 5/6/2021 - 3 years ago

  32 - TEAS REQUEST TO DIVIDE RECEIVED Type: ERTD

• 5/6/2021 - 3 years ago

  31 - TEAS STATEMENT OF USE RECEIVED Type: EISU

• 3/3/2021 - 4 years ago

  30 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 3/1/2021 - 4 years ago

  29 - SOU EXTENSION 1 GRANTED Type: EX1G

• 3/1/2021 - 4 years ago

  28 - SOU EXTENSION 1 FILED Type: EXT1

• 3/1/2021 - 4 years ago

  27 - TEAS EXTENSION RECEIVED Type: EEXT

• 9/1/2020 - 4 years ago

  26 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 7/23/2020 - 4 years ago

  25 - EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED Type: ETOP

• 6/26/2020 - 4 years ago

  24 - CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED Type: CHPB

• 6/24/2020 - 4 years ago

  23 - ASSIGNED TO PETITION STAFF Type: APET

• 6/2/2020 - 4 years ago

  22 - TEAS POST PUBLICATION AMENDMENT RECEIVED Type: EPPA

• 2/11/2020 - 5 years ago

  21 - EXTENSION OF TIME TO OPPOSE RECEIVED Type: ETOF

• 1/14/2020 - 5 years ago

  20 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 1/14/2020 - 5 years ago

  19 - PUBLISHED FOR OPPOSITION Type: PUBO

• 12/25/2019 - 5 years ago

  18 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 12/12/2019 - 5 years ago

  17 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 12/11/2019 - 5 years ago

  16 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 12/11/2019 - 5 years ago

  15 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 12/11/2019 - 5 years ago

  14 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 6/11/2019 - 5 years ago

  13 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 6/11/2019 - 5 years ago

  12 - NON-FINAL ACTION E-MAILED Type: GNRT

• 6/11/2019 - 5 years ago

  11 - NON-FINAL ACTION WRITTEN Type: CNRT

• 6/4/2019 - 5 years ago

  10 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 6/4/2019 - 5 years ago

  9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 6/4/2019 - 5 years ago

  8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 6/4/2019 - 5 years ago

  7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 12/6/2018 - 6 years ago

  6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 12/6/2018 - 6 years ago

  5 - NON-FINAL ACTION E-MAILED Type: GNRT

• 12/6/2018 - 6 years ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 12/3/2018 - 6 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 8/25/2018 - 6 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 8/20/2018 - 6 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP